HCSC(600378)2025-04-29 16:20Financial Performance - Haohua Technology achieved a net profit attributable to shareholders of 1,053,796,305.15 yuan for the fiscal year 2024[6]. - The company's operating revenue for 2024 was approximately CNY 13.97 billion, a decrease of 3.83% compared to CNY 14.52 billion in 2023[25]. - The net profit attributable to shareholders for 2024 was approximately CNY 1.05 billion, down 10.94% from CNY 1.18 billion in 2023[25]. - The basic earnings per share for 2024 was CNY 0.9531, reflecting a decrease of 10.71% compared to CNY 1.0674 in 2023[24]. - The weighted average return on equity for 2024 was 8.66%, a decrease of 1.20 percentage points from 9.86% in 2023[24]. - The net cash flow from operating activities for 2024 was approximately CNY 738.23 million, down 30.53% from CNY 1.06 billion in 2023[25]. - The total assets at the end of 2024 were approximately CNY 30.15 billion, an increase of 18.86% from CNY 25.37 billion at the end of 2023[25]. - The net assets attributable to shareholders at the end of 2024 were approximately CNY 17.12 billion, up 44.61% from CNY 11.84 billion at the end of 2023[25]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of 2.86 yuan per 10 shares, totaling 368,949,639.63 yuan, based on a total share capital of 1,290,033,705 shares[6]. - The company will submit the profit distribution plan for shareholder approval at the 2024 annual general meeting[6]. - The total profit distribution for 2023 amounted to ¥315,369,937.22, representing approximately 35.05% of the net profit attributable to shareholders of the listed company for the year[188]. Corporate Governance and Compliance - Haohua Technology's board of directors and management have confirmed the accuracy and completeness of the financial report[5]. - The company has not reported any significant risks that could materially affect its operations during the reporting period[9]. - The company has no non-operating fund occupation by controlling shareholders or related parties[8]. - There are no violations of decision-making procedures regarding external guarantees[8]. - The audit report issued by Tianzhi International Accounting Firm confirms the financial report's standard unqualified opinion[5]. - The company held 4 shareholder meetings, 14 board meetings, and 10 supervisory meetings during the reporting period, demonstrating its commitment to corporate governance[186]. - The board has established four specialized committees to enhance decision-making and oversight, ensuring compliance with regulations and protecting shareholder interests[187]. Research and Development - The total R&D expenditure amounted to CNY 928,030,116.54, representing 6.64% of total revenue[8]. - The number of R&D personnel increased from 2,927 to 3,283, now comprising 28% of the total workforce[9]. - The company has maintained an average R&D investment intensity of around 7% over the past three years, positioning it at the forefront of the industry[75]. - The company has received over 400 significant technology awards, including more than 30 national technology invention and progress awards, showcasing its strong R&D capabilities[71]. - The company has established a multi-level R&D platform system with over 10 national-level research platforms and more than 40 provincial-level platforms, enhancing its innovation capabilities[72]. Market Expansion and Strategic Initiatives - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[23]. - The company is focusing on enhancing its supply chain efficiency and compliance through training and monitoring, aiming for sustainable development in procurement practices[42]. - The company is actively expanding its industrial chain and enhancing its collaborative innovation capabilities across upstream and downstream sectors[80]. - The company is focusing on expanding its market presence and enhancing its financial services capabilities through strategic partnerships[195]. - The company is committed to improving operational efficiency and aims for over 50% of enterprises to reach "G4 leading level"[173]. Environmental and Safety Management - The company maintained a 100% compliance rate in occupational health checks and did not experience any major safety incidents during the reporting period[41]. - The company’s HSE management achieved the "four zeros" goal, indicating no major safety production accidents or environmental incidents[41]. - The company aims to achieve zero incidents of general and above production safety accidents, zero general and above environmental incidents, zero new occupational diseases, and zero major HSE negative public opinion as part of its HSE management goals[179]. Financial Position and Investments - Cash and cash equivalents increased by 76.01% to CNY 5,457,164,847.32 compared to the previous period[10]. - The company's equity capital increased by 41.53% year-over-year, attributed to the completion of a major asset restructuring and the issuance of new shares[104]. - The company raised 4.5 billion RMB through share issuance during the reporting period[85]. - The company completed the acquisition of 100% equity in Sinochem Blue Sky Group, significantly increasing its share in high-end fluorine materials and expanding product categories[5]. Future Outlook - The company anticipates a recovery and moderate growth in the chemical industry, driven by improved supply-demand dynamics and policy support[167]. - The company aims to achieve operating revenue of 16.103 billion yuan and a net profit of 1.276 billion yuan by 2025[170]. - The company is focusing on enhancing core functions and competitiveness through technology innovation and increasing R&D investment[170]. - The company is committed to increasing R&D investment to enhance its technological capabilities and achieve self-sufficiency in key chemical materials[183].